Takeda investors back $59 billion Shire deal, but wary of debt load
2018-12-5 03:51 pm
Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt.
Read The Rest at
Thomas Cook shares climb 45 percent but bonds...
Thyssenkrupp's top shareholder appoints...
You May Also Like
A 72-year-old Dallas man fatally shot a...
Chase Elliott roars back from 37th to 1st in...
Celebrate 64 Years of Arthur Miller's A View...
Rutgers could turn back to Greg Schiano after...
JSPL aims to reduce net debt to below Rs 30K...
Saudi Arabia to invest $100 billion in India
Berlin / Germany
Sydney / Australia
All Rights Reserved
Powered By RSS-Script Light Version